Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer
Go back to Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer| (NASDAQ: AUTL) | Delayed: 1.66 +0.04 (2.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.62 | 52 Week High | $ | |||
| Open | $1.64 | 52 Week Low | $ | |||
| Day High | $1.76 | P/E | N/A | |||
| Day Low | $1.64 | EPS | $ | |||
| Volume | 1,272,823 | |||||
| (NASDAQ: GANX) | Delayed: 1.86 +0.07 (3.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.79 | 52 Week High | $ | |||
| Open | $1.79 | 52 Week Low | $ | |||
| Day High | $1.90 | P/E | N/A | |||
| Day Low | $1.79 | EPS | $ | |||
| Volume | 369,390 | |||||
| Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) | Delayed: 18.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.00 | 52 Week High | $18.75 | |||
| Open | $1.35 | 52 Week Low | $9.59 | |||
| Day High | $18.00 | P/E | 42.86 | |||
| Day Low | $18.00 | EPS | $0.42 | |||
| Volume | 200 | |||||
